Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

166.69
+0.86000.52%
Pre-market: 167.901.21+0.73%09:24 EDT
Volume:9.64M
Turnover:1.61B
Market Cap:401.33B
PE:28.79
High:168.46
Open:165.13
Low:164.70
Close:165.83
Loading ...

Company Profile

Company Name:
Johnson & Johnson
Exchange:
NYSE
Establishment Date:
1886
Employees:
138100
Office Location:
One Johnson & Johnson Plaza,New Brunswick,New Jersey,United States
Zip Code:
08933
Fax:
- -
Introduction:
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Directors

Name
Position
Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Joaquin Duato
Chairman of the Board and Chief Executive Officer
Tim Schmid
Executive Vice President, Worldwide Chairman, MedTech
Anne M. Mulcahy
Director
Darius Adamczyk
Director
Eugene A. Woods
Director
H. Joly
Director
J. A. Doudna
Director
M. A. Hewson
Director
M. A. Weinberger
Director
Mark B. McClellan
Director
Nadja Y. West
Director
Paula A. Johnson
Director

Shareholders

Name
Position
Joaquin Duato
Chairman of the Board and Chief Executive Officer
Joseph J. Wolk
Executive Vice President, Chief Financial Officer
Elizabeth Forminard
Executive Vice President, Chief Legal Officer
James Swanson
Executive Vice President, Chief Information Officer
John C. Reed
Executive Vice President, Innovative Medicine, R&D
Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Kristen Mulholland
Executive Vice President, Chief Human Resources Officer
Vanessa Broadhurst
Executive Vice President, Global Corporate Affairs